Annual Working Capital
$6.36 M
+$333.10 K+5.53%
December 1, 2023
Summary
- As of February 7, 2025, DRMA annual working capital is $6.36 million, with the most recent change of +$333.10 thousand (+5.53%) on December 1, 2023.
- During the last 3 years, DRMA annual working capital has risen by +$9.53 million (+299.97%).
- DRMA annual working capital is now -37.12% below its all-time high of $10.11 million, reached on December 31, 2021.
Performance
DRMA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$4.74 M
+$1.42 M+42.88%
September 1, 2024
Summary
- As of February 7, 2025, DRMA quarterly working capital is $4.74 million, with the most recent change of +$1.42 million (+42.88%) on September 1, 2024.
- Over the past year, DRMA quarterly working capital has dropped by -$1.61 million (-25.39%).
- DRMA quarterly working capital is now -62.04% below its all-time high of $12.49 million, reached on September 30, 2021.
Performance
DRMA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DRMA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.5% | -25.4% |
| 3 y3 years | +300.0% | -41.0% |
| 5 y5 years | +1754.4% | -41.0% |
DRMA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.1% | +5.5% | -53.1% | +42.9% |
| 5 y | 5-year | -37.1% | +300.0% | -62.0% | +249.2% |
| alltime | all time | -37.1% | +300.0% | -62.0% | +249.2% |
Dermata Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.74 M(+42.9%) |
| Jun 2024 | - | $3.32 M(-12.9%) |
| Mar 2024 | - | $3.81 M(-40.1%) |
| Dec 2023 | $6.36 M(+5.5%) | $6.36 M(-0.8%) |
| Sep 2023 | - | $6.41 M(-20.2%) |
| Jun 2023 | - | $8.03 M(-0.7%) |
| Mar 2023 | - | $8.09 M(+34.3%) |
| Dec 2022 | $6.02 M | $6.02 M(-19.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $7.47 M(-22.7%) |
| Jun 2022 | - | $9.66 M(+23.0%) |
| Mar 2022 | - | $7.85 M(-22.3%) |
| Dec 2021 | $10.11 M(-418.0%) | $10.11 M(-19.1%) |
| Sep 2021 | - | $12.49 M(-2569.5%) |
| Jun 2021 | - | -$505.80 K(-171.0%) |
| Mar 2021 | - | $712.00 K(-122.4%) |
| Dec 2020 | -$3.18 M(-1027.3%) | -$3.18 M |
| Dec 2019 | $342.70 K | - |
FAQ
- What is Dermata Therapeutics annual working capital?
- What is the all time high annual working capital for Dermata Therapeutics?
- What is Dermata Therapeutics annual working capital year-on-year change?
- What is Dermata Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Dermata Therapeutics?
- What is Dermata Therapeutics quarterly working capital year-on-year change?
What is Dermata Therapeutics annual working capital?
The current annual working capital of DRMA is $6.36 M
What is the all time high annual working capital for Dermata Therapeutics?
Dermata Therapeutics all-time high annual working capital is $10.11 M
What is Dermata Therapeutics annual working capital year-on-year change?
Over the past year, DRMA annual working capital has changed by +$333.10 K (+5.53%)
What is Dermata Therapeutics quarterly working capital?
The current quarterly working capital of DRMA is $4.74 M
What is the all time high quarterly working capital for Dermata Therapeutics?
Dermata Therapeutics all-time high quarterly working capital is $12.49 M
What is Dermata Therapeutics quarterly working capital year-on-year change?
Over the past year, DRMA quarterly working capital has changed by -$1.61 M (-25.39%)